Cite

    Kullar, R. et al. (n.d.). Does moderate renal impairment affect clinical outcomes in complicated intra-abdominal and complicated urinary tract infections? Analysis of two randomized controlled trials with ceftolozane/tazobactam. Journal of antimicrobial chemotherapy. pp. 900-905. [Online].